相似文献
1
Vascular alterations upon activation of TGFbeta signaling in fibroblasts--implications for systemic sclerosis.
Arthritis Res Ther. 2010;12(3):125. doi: 10.1186/ar3026. Epub 2010 Jun 18.
2
Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.
Am J Physiol Lung Cell Mol Physiol. 2017 Jan 1;312(1):L22-L31. doi: 10.1152/ajplung.00428.2016. Epub 2016 Nov 18.
3
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Arthritis Rheum. 2007 Jan;56(1):334-44. doi: 10.1002/art.22328.
4
An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Arthritis Rheum. 2004 May;50(5):1566-77. doi: 10.1002/art.20225.
5
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Arthritis Rheumatol. 2014 Nov;66(11):3140-50. doi: 10.1002/art.38819.
6
Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
Arthritis Rheum. 2013 Nov;65(11):2928-39. doi: 10.1002/art.38078.
7
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.
J Biol Chem. 2003 Jul 4;278(27):25109-19. doi: 10.1074/jbc.M300636200. Epub 2003 Apr 21.
8
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Arthritis Rheum. 2013 Jan;65(1):258-69. doi: 10.1002/art.37705.
9
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
Ann Rheum Dis. 2016 Mar;75(3):586-92. doi: 10.1136/annrheumdis-2014-206214. Epub 2015 Jan 14.
10
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
Ann Rheum Dis. 2015 Jul;74(7):1408-16. doi: 10.1136/annrheumdis-2013-204508. Epub 2014 Feb 23.
引用本文的文献
1
Evaluation of Peripheral Blood Circulation Disorder in Scleroderma Patients Using an Optical Sensor with a Pressurization Mechanism.
PLoS One. 2016 Aug 1;11(8):e0159611. doi: 10.1371/journal.pone.0159611. eCollection 2016.
本文引用的文献
1
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.
Arthritis Res Ther. 2010;12(2):R69. doi: 10.1186/ar2986. Epub 2010 Apr 15.
2
Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.
Circulation. 2009 Dec 8;120(23):2367-76. doi: 10.1161/CIRCULATIONAHA.109.855114. Epub 2009 Nov 23.
3
Scleroderma.
N Engl J Med. 2009 May 7;360(19):1989-2003. doi: 10.1056/NEJMra0806188.
4
Systemic sclerosis: a prototypic multisystem fibrotic disorder.
J Clin Invest. 2007 Mar;117(3):557-67. doi: 10.1172/JCI31139.
5
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Arthritis Rheum. 2007 Jan;56(1):334-44. doi: 10.1002/art.22328.
6
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Arthritis Rheum. 2007 Jan;56(1):311-22. doi: 10.1002/art.22314.
7
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.
J Biol Chem. 2003 Jul 4;278(27):25109-19. doi: 10.1074/jbc.M300636200. Epub 2003 Apr 21.
8
Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1.
J Invest Dermatol. 2002 Dec;119(6):1379-87. doi: 10.1046/j.1523-1747.2002.19614.x.
9
Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
J Biol Chem. 2001 Oct 12;276(41):38121-38. doi: 10.1074/jbc.M105408200. Epub 2001 Jul 16.
10
Electron microscopic observations of elastic fibres in the lung and aorta of tight-skin and beta-aminopropionitrile-fed mice.
Histol Histopathol. 1992 Jan;7(1):39-45.
Zotero 插件